Riskpilot← Back to searchSign inGet full accessCELLECTEVE AB
ABActiveOrg 5592370976Wadströmsgatan 2 BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20200 employees
Revenue 2025
SEK 0
EBITDA margin
—
0% vs 2024
Equity ratio
87.6%
Financial strength
Net profit 2025
SEK -6K
-2% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK -6K | -2% |
| Total assets | SEK 80K | -7% |
| Equity | SEK 70K | -8% |
| Employees | 0 | — |
Legal name
CELLECTEVE AB
Org number
5592370976
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva kontraktsforskning och konsultuppdrag inom bioteknologi och därmed förenlig verksamhet.
Address
Wadströmsgatan 2 B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 93 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −63 | −70 | −11 | −1 | −1 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −5 |
| EBIT | −68 | −75 | −17 | −7 | −7 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | −68 | 25 | −16 | −6 | −6 |
| Tax | −0 | — | — | — | — |
| Net profit | −68 | 25 | −16 | −6 | −6 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 79 | 109 | 93 | 87 | 80 |
| Equity | 24 | 99 | 83 | 77 | 70 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 55 | 10 | 10 | 10 | 10 |
| Total debt | 55 | 10 | 10 | 10 | 10 |
EBITDA margin
-130000.0%
This company
15.8%
Market median
-822885% vs market
20212025
Equity ratio
87.6%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
-9.1%
This company
18.4%
Market median
-149% vs market
20212025
Net profit margin
-637200.0%
This company
8.1%
Market median
-7866767% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-01-01 – 2021-06-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Koshi Capital AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Koshi Capital AB
CELLECTEVE AB Board members of CELLECTEVE AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Max Hamedi | Board of Directors | 0 companies |
| Anna Herland | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |